Jason Gerberry

Aug 24, 2026

Target

$7.00

Current

$5.29

Performance

0.76%

Jason Gerberry rated ALVO as Buy on Aug 24, 2026, setting a price target of 7. Shares have remained stable near 5.29, leaving the 7 target still in play.

PFE

Jul 10, 2026

Target

$26.00

Current

$27.72

Performance

14.69%

On Jul 10, 2026, PFE was given a Neutral rating by Jason Gerberry, with a target price of 26. The stock rallied from 27.72 to 27.72 after the Hold rating, surprising to the upside.

LLY

Jul 10, 2026

Target

$1334.00

Current

$1115.25

Performance

-6.17%

LLY received a Buy rating from Jason Gerberry on Jul 10, 2026, aiming for 1334. The rating hasn’t played out as hoped, with the stock trading 6.17% below expectations.

ALKS

Jun 29, 2026

Target

$38.00

Current

$45.97

Performance

-12.49%

On Jun 29, 2026, Jason Gerberry published a Underperform outlook on ALKS, with a target of 38. The Sell recommendation underestimated bullish momentum toward 38.

LQDA

Jun 29, 2026

Target

$79.00

Current

$66.74

Performance

-11.16%

Jason Gerberry on Jun 29, 2026 assigned LQDA a Neutral rating, with a price target of 79. The call successfully avoided chasing as shares lost 11.16%.

BHVN

Jun 29, 2026

Target

$11.00

Current

$12.71

Performance

-14.98%

On Jun 29, 2026, Jason Gerberry reaffirmed BHVN with a Underperform rating, targeting 11. The outlook was invalidated by a rebound to 12.71.

AMPH

Jun 29, 2026

Target

$20.00

Current

$23.78

Performance

14.82%

AMPH was rated Underperform by Jason Gerberry on Jun 29, 2026, with a price objective of 20. Bearish sentiment was justified as the stock retreated to 23.78.

JAZZ

Jun 10, 2026

Target

$307.00

Current

$245.80

Performance

7.04%

On Jun 10, 2026, Jason Gerberry initiated coverage on JAZZ with a Buy rating and target of 307. The stock’s climb of 7.04% since the call highlights the foresight in the rating.

IMVT

May 21, 2026

Target

$43.00

Current

$37.36

Performance

9.46%

Jason Gerberry issued a Buy recommendation for IMVT on May 21, 2026, price target set at 43. Investors following the Buy call captured upside momentum, with shares now at 37.36.

TEVA

Apr 09, 2026

Target

$42.00

Current

$37.09

Performance

19.80%

On Apr 09, 2026, TEVA was evaluated by Jason Gerberry, who gave a Buy rating and target of 42. This case illustrates how a timely bullish rating can translate into tangible gains of 19.80%.

IONS

Apr 09, 2026

Target

$111.00

Current

$54.21

Performance

-29.07%

Jason Gerberry rated IONS as Buy on Apr 09, 2026, setting a price target of 111. The stock has underperformed, dropping 29.07% despite the bullish target of 111.

LENZ

Mar 25, 2026

Target

$29.00

Current

$4.52

Performance

-50.17%

On Mar 25, 2026, LENZ was given a Buy rating by Jason Gerberry, with a target price of 29. Despite the Buy call, shares fell from 4.52 to 4.52, challenging the optimistic stance.

HRMY

Feb 25, 2026

Target

$32.00

Current

$41.52

Performance

47.29%

HRMY received a Underperform rating from Jason Gerberry on Feb 25, 2026, aiming for 32. Shares declined 47.29%, matching the cautious outlook.

ARWR

Dec 09, 2025

Target

$81.00

Current

$82.85

Performance

20.37%

On Dec 09, 2025, Jason Gerberry published a Buy outlook on ARWR, with a target of 81. Shares gained 20.37%, underscoring the accuracy of the bullish outlook toward 81.

OCS

Nov 13, 2025

Target

$29.00

Current

$10.56

Performance

-45.26%

Jason Gerberry on Nov 13, 2025 assigned OCS a Buy rating, with a price target of 29. The call has struggled to gain traction, with shares losing 45.26%.

AXSM

Aug 05, 2025

Target

$176.00

Current

$220.75

Performance

113.10%

On Aug 05, 2025, Jason Gerberry reaffirmed AXSM with a Buy rating, targeting 176. The recommendation was supported by strong follow-through as the stock rose from 220.75 to 220.75.

PROK

Jun 30, 2025

Target

$1.00

Current

$1.80

Performance

204.00%

PROK was rated Underperform by Jason Gerberry on Jun 30, 2025, with a price objective of 1. Bearish sentiment was justified as the stock retreated to 1.8.

EXEL

Jun 05, 2025

Target

$46.00

Current

$56.12

Performance

32.45%

On Jun 05, 2025, Jason Gerberry initiated coverage on EXEL with a Neutral rating and target of 46. The Hold stance underestimated the stock’s strength as it gained 32.45%.

PCVX

Apr 01, 2025

Target

$137.00

Current

$59.47

Performance

84.52%

Jason Gerberry issued a Buy recommendation for PCVX on Apr 01, 2025, price target set at 137. Investors following the Buy call captured upside momentum, with shares now at 59.47.

VTRS

Feb 28, 2025

Target

$10.00

Current

$16.51

Performance

78.87%

On Feb 28, 2025, VTRS was evaluated by Jason Gerberry, who gave a Underperform rating and target of 10. Investors benefited from heeding the Sell stance, avoiding a 78.87% decline.

CPRX

Jan 09, 2025

Target

$30.00

Current

$31.49

Performance

—

Jason Gerberry rated CPRX as Buy on Jan 09, 2025, setting a price target of 30. Shares have remained stable near 31.49, leaving the 30 target still in play.

BLUE

Nov 15, 2024

Target

$10.00

Current

$4.97

Performance

-22.59%

On Nov 15, 2024, BLUE was given a Neutral rating by Jason Gerberry, with a target price of 10. The rating provided protection from downside risk as the stock fell to 4.97.

RLAY